Zhang J - Search Results

1

Inhibition of interleukin-6 with CNTO328, an anti-interleukin-6 monoclonal antibody, inhibits conversion of androgen-dependent prostate cancer to an androgen-independent phenotype in orchiectomized mice.

Wallner L, Dai J, Escara-Wilke J, Zhang J, Yao Z, Lu Y, Trikha M, Nemeth JA, Zaki MH, Keller ET. Wallner L, et al. Among authors: zhang j. Cancer Res. 2006 Mar 15;66(6):3087-95. doi: 10.1158/0008-5472.CAN-05-3447. Cancer Res. 2006. PMID: 16540658

2

Soluble receptor activator of nuclear factor kappaB Fc diminishes prostate cancer progression in bone.

Zhang J, Dai J, Yao Z, Lu Y, Dougall W, Keller ET. Zhang J, et al. Cancer Res. 2003 Nov 15;63(22):7883-90. Cancer Res. 2003. PMID: 14633717

3

Vascular endothelial growth factor contributes to the prostate cancer-induced osteoblast differentiation mediated by bone morphogenetic protein.

Dai J, Kitagawa Y, Zhang J, Yao Z, Mizokami A, Cheng S, Nör J, McCauley LK, Taichman RS, Keller ET. Dai J, et al. Among authors: zhang j. Cancer Res. 2004 Feb 1;64(3):994-9. doi: 10.1158/0008-5472.can-03-1382. Cancer Res. 2004. PMID: 14871830

4

Osteoblasts induce prostate cancer proliferation and PSA expression through interleukin-6-mediated activation of the androgen receptor.

Lu Y, Zhang J, Dai J, Dehne LA, Mizokami A, Yao Z, Keller ET. Lu Y, et al. Among authors: zhang j. Clin Exp Metastasis. 2004;21(5):399-408. doi: 10.1007/s10585-005-0056-6. Clin Exp Metastasis. 2004. PMID: 15672864 Free article.

5

Bone morphogenetic protein-6 promotes osteoblastic prostate cancer bone metastases through a dual mechanism.

Dai J, Keller J, Zhang J, Lu Y, Yao Z, Keller ET. Dai J, et al. Among authors: zhang j. Cancer Res. 2005 Sep 15;65(18):8274-85. doi: 10.1158/0008-5472.CAN-05-1891. Cancer Res. 2005. PMID: 16166304

6

The bisphosphonate YM529 inhibits osteolytic and osteoblastic changes and CXCR-4-induced invasion in prostate cancer.

Miwa S, Mizokami A, Keller ET, Taichman R, Zhang J, Namiki M. Miwa S, et al. Among authors: zhang j. Cancer Res. 2005 Oct 1;65(19):8818-25. doi: 10.1158/0008-5472.CAN-05-0540. Cancer Res. 2005. PMID: 16204052

7

Vascular endothelial growth factor contributes to prostate cancer-mediated osteoblastic activity.

Kitagawa Y, Dai J, Zhang J, Keller JM, Nor J, Yao Z, Keller ET. Kitagawa Y, et al. Among authors: zhang j. Cancer Res. 2005 Dec 1;65(23):10921-9. doi: 10.1158/0008-5472.CAN-05-1809. Cancer Res. 2005. PMID: 16322239

8

Reversal of chemotherapy-induced leukopenia using granulocyte macrophage colony-stimulating factor promotes bone metastasis that can be blocked with osteoclast inhibitors.

Dai J, Lu Y, Yu C, Keller JM, Mizokami A, Zhang J, Keller ET. Dai J, et al. Among authors: zhang j. Cancer Res. 2010 Jun 15;70(12):5014-23. doi: 10.1158/0008-5472.CAN-10-0100. Epub 2010 May 25. Cancer Res. 2010. PMID: 20501834 Free PMC article.

9

Osteoprotegerin abrogates chronic alcohol ingestion-induced bone loss in mice.

Zhang J, Dai J, Lin DL, Habib P, Smith P, Murtha J, Fu Z, Yao Z, Qi Y, Keller ET. Zhang J, et al. J Bone Miner Res. 2002 Jul;17(7):1256-63. doi: 10.1359/jbmr.2002.17.7.1256. J Bone Miner Res. 2002. PMID: 12096839 Free article.

10

Characterization of C4-2 prostate cancer bone metastases and their response to castration.

Pfitzenmaier J, Quinn JE, Odman AM, Zhang J, Keller ET, Vessella RL, Corey E. Pfitzenmaier J, et al. Among authors: zhang j. J Bone Miner Res. 2003 Oct;18(10):1882-8. doi: 10.1359/jbmr.2003.18.10.1882. J Bone Miner Res. 2003. PMID: 14584899 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

176,515 results

Search Page

Filters